Contract Manufacturing Drugs Packaging Pharma Companies 
Pharmaceutical Technology
AUGUST 16, 2022
Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Outsourcing may also be pursued if it is more favourable in terms of time and/or cost.
Pharmaceutical Technology
JULY 14, 2022
Regulatory decisions have a ripple effect, first affecting the pharma sponsors, and then the companies tasked to manufacture the drug. Pharmaceutical Technology looks at drugs and biologics with recent regulatory verdicts that will likely impact manufacturing volumes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JULY 15, 2022
The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. The documents state that a partnership with a CMO would be cheaper than the state directly manufacturing insulin. Prices would be “a fraction of the $300 per vial prices charged by insulin manufacturers.”.
Pharmaceutical Technology
SEPTEMBER 8, 2022
Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups. Find the leading pharmaceutical solid dose manufacturing companies in contract marketing.
Pharmaceutical Technology
JUNE 14, 2023
Navigating the complexities of pharma and biotech packaging services can be difficult. Packaging trends The pharmaceutical contract packaging market is witnessing substantial growth. Small molecules only accounted for 41% of NME (New Molecular Entity) approvals in 2022.
Pharmaceutical Technology
AUGUST 30, 2022
Only a limited number of international pharma companies, however, operate manufacturing sites in the country. On 9 May this year, Merck & Co (Kenilworth, New Jersey) entered an agreement with Oswaldo Cruz Foundation (Fiocruz) (Rio de Janeiro, Brazil) for the manufacturing of the Covid-19 antiviral molnupiravir.
Pharmaceutical Technology
JULY 4, 2022
Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.
Expert insights. Personalized for you.
162 
Let's personalize your content